EICHOR
● Active Not Recruiting
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
Condition: Breast Neoplasms · Neoplasm Metastasis · Sponsor: Eli Lilly and Company
About this study
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaciclib work compared to imlunestrant in participants with breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have breast cancer that is advanced or has spread to another part of the body. Study participation could last up to 5 years.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (243)
| Ironwood Cancer & Research Centers | Chandler, Arizona, United States | — |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Marin Cancer Care | Greenbrae, California, United States | — |
| University of California Davis (UC Davis) Comprehensive Cancer Center | Sacramento, California, United States | — |
| Sharp Memorial Hospital | San Diego, California, United States | — |
| Banner MD Anderson Cancer Center at McKee Medical Center | Loveland, Colorado, United States | — |
| Clermont Oncology Center | Clermont, Florida, United States | — |
| University of Florida College of Medicine | Gainesville, Florida, United States | — |
| Mid Florida Hematology and Oncology Center | Orange City, Florida, United States | — |
| Florida Cancer Specialists | Sarasota, Florida, United States | — |
| Florida Cancer Specialists | St. Petersburg, Florida, United States | — |
| Kaiser Permanente Moanalua Medical Center | Honolulu, Hawaii, United States | — |
+ 231 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04975308